Steven J Burakoff, MD
img_Steven J Burakoff
FOUNDING CHAIR EMERITUS AND PROFESSOR | Oncological Sciences
FOUNDING CHAIR EMERITUS AND PROFESSOR | Medicine, Hematology and Medical Oncology
PROFESSOR | Pediatrics, Hematology/Oncology
Research Topics
T Cells
Multi-Disciplinary Training Area
Cancer Biology [CAB], Immunology [IMM]
Major Research Interests:

   1. Cellular and molecular immunology;
   2. T cell activation and signal transduction;
   3. Transplantation immunology.

MA, Queens College

MA (hon), Harvard University

Harvard Medical School

New York Hospital-Cornell Medical Center

Rockefeller University

2009

Lifetime Achievement Award

American Association of Immunologists

2006

Lynne Cohen Foundation Awardee

2003

Distinguished Alumnus 2003

2002

Theobold Smith Alumni Lecture

Albany Medical College

2001

ISI Highly Cited Researcher (1980-2000)

2000

Laura and Isaac Perlmutter Professor

New York University, School of Medicine

1998

Margaret M. Dyson Professor of Pediatrics

Harvard Medical School

1995

Ted Williams Senior Investigator

Dana-Farber Cancer Institute

1995

Association of American Physicians

1994

Horizons in Biomedical Research Lecture

Cleveland Clinic Foundation

1992

David A. Talmadge Lecture

Colorado Allergy Society

Steven Burakoff, MD

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Burakoff did not report having any of the following types of financial relationships with industry and other outside entities during 2023 and/or 2024: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.